Award recordCONTRACT

GOLDEN STATE MEDICAL SUPPLY, INC.

PIID VA25515P1970· VHA· NATIONAL CMOP OFFICE (NCO)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $2,108,395 net obligations· UEI GQLDJJ8AQNN5· CA

Description

TAMSULOSIN HCL 0.04MG CAPSULE, 100&500 COUNT

First action · last action
2015-01-29 · 2015-02-03
Transactions
2
First transaction's obligation
$2,108,403
Base + all options value (sum of deltas)
$2,108,395
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,108,403$0Base award · 2015-01-29 · this action $2,108,403 · running total $2,108,403Modification P00001 · 2015-02-03 · this action -$8 · running total $2,108,395
  • Base2015-01-29+$2,108,403= $2,108,403
  • Mod P000012015-02-03-$8= $2,108,395
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-01-29+$2,108,403$2,108,403TAMSULOSIN HCL 0.04MG CAPSULE, 100&500 COUNT
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2015-02-03−$8$2,108,395TAMSULOSIN HCL 0.04MG CAPSULE, 100&500 COUNT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)

AwardOffice · PSC / listingNet obligationsFY
36E79726D0041NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0042NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0022NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0014NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026

Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)

AwardRecipientOfficeNet obligationsFY
VA77016P0844ROCHE DIABETES CARE INCNATIONAL CMOP OFFICE (NCO)$494,384FY2016
VA77016P0843D & H WHOLESALE MEDICAL, INC.NATIONAL CMOP OFFICE (NCO)$30,360FY2016
VA77016P0828WESTMINSTER PHARMACEUTICALS, LLCNATIONAL CMOP OFFICE (NCO)$24,615FY2016
VA77016E0865SOUND PACKAGING LLCNATIONAL CMOP OFFICE (NCO)$11,462FY2016
VA77016E08623M COMPANYNATIONAL CMOP OFFICE (NCO)$9,177FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25515P1970_3600_-NONE-_-NONE- · retrieved 2026-09-26.